Home/ Resources/ Off-the-Clot vs. Plasma-Derived
Human Serum · Technical Guide

Off-the-Clot vs. Plasma-Derived Human Serum — Why the Collection Method Changes Your Culture

Both products are sold as "human serum". They are made in fundamentally different ways, and for sensitive primary cells the difference is measurable.

In short Off-the-clot serum comes from whole blood that clotted naturally, with no anticoagulant involved at any point. Plasma-derived serum starts from anticoagulated plasma that is later clotted artificially by adding calcium. The consequences are a different growth factor profile and residual citrate — which matters for MSC expansion, primary cells and calcium-dependent assays, and rarely matters for established cell lines.

How off-the-clot serum is made

No anticoagulant touches the blood at any stage.

  1. Whole blood donation into a plain tube or bag — no citrate, no EDTA, no heparin.
  2. Natural clotting. The coagulation cascade runs its physiological course. Thrombin is generated, fibrinogen converts to fibrin, and a clot forms.
  3. Platelet activation. As the clot forms, platelets degranulate and release their α-granule contents into the surrounding fluid — PDGF, TGF-β, VEGF, EGF and IGF-1 among them.
  4. Clot retraction under refrigeration, then centrifugation.
  5. Serum is drawn off the clot. What remains in solution is the serum, now depleted of fibrinogen and the consumed coagulation factors, and enriched with everything the platelets released.

That last point is the one that matters commercially. The growth factors in off-the-clot serum are there because the clotting process put them there. They are not an additive.

How plasma-derived serum is made

Clotting is prevented first, then induced later — out of sequence.

  1. Collection with anticoagulant, usually sodium citrate. Citrate works by chelating calcium, and calcium is required at several steps of the coagulation cascade.
  2. Plasma separation from the cellular fraction. Depending on the process, most platelets are removed at this stage.
  3. Recalcification. Calcium chloride is added to overcome the citrate block and force clotting.
  4. The fibrin clot is removed, and what remains is sold as serum.

Chemically the product resembles serum. Three things are systematically different.

Fewer platelet-derived growth factors

If platelets were removed during plasma preparation, they were not present to degranulate when clotting was finally induced. The growth factors they would have released are simply absent.

This is the single largest functional difference, and it is why the two products can perform differently in the same culture.

Residual citrate and altered ions

Citrate is not removed — it stays in the product as calcium-citrate complexes. Sodium citrate also adds a sodium load, and recalcification adds chloride.

Free calcium in your medium is therefore lower than the nominal figure suggests.

And a third, less discussed: residual fibrinogen

If recalcification is incomplete, some fibrinogen survives the process. In practice this shows up as gel or fibre formation after freeze-thaw, or as stringy material in the culture vessel. It is not common, but when a serum lot behaves this way, incomplete recalcification is a likely explanation.

Side by side

Off-the-clotPlasma-derived (recalcified)
Starting materialWhole blood, no additiveAnticoagulated plasma
ClottingNatural, physiological sequenceInduced later by adding calcium
Platelet growth factorsReleased into the serum during clottingReduced or absent, depending on process
Residual anticoagulantNoneCitrate present
Free calciumPhysiologicalPartly bound by citrate
Residual fibrinogen riskVery lowPossible if recalcification incomplete
Collection methodWhole blood donationOften plasmapheresis
AvailabilityLimitedGood
PriceHigherLower

Why off-the-clot is scarcer and more expensive

It is a supply constraint, not a margin decision.

Off-the-clot serum requires a whole blood donation. Plasmapheresis — where plasma is collected and the cells returned to the donor — yields far more usable volume per donation and can be repeated much more frequently. It is the dominant collection method, particularly in the United States, and it produces plasma, not serum.

The scarcity compounds when you also need a blood group: Type AB donors are roughly four percent of the European population, and off-the-clot Type AB is the intersection of two limited pools.

Practical consequence: if your process depends on off-the-clot Type AB serum, treat availability as a project risk rather than a purchasing detail. Reserving a lot is cheaper than re-validating when your specification sells out.

When the difference actually matters

Specify off-the-clot for

  • MSC expansion and ATMP processes — proliferation depends directly on the growth factor profile
  • Primary human cells, especially slow-growing ones
  • Calcium-dependent assays and signalling work — residual citrate lowers free calcium
  • Integrin-mediated adhesion studies — integrin binding is calcium and magnesium dependent
  • Any process replacing FBS with human serum, where performance has to be matched

Plasma-derived is fine for

  • Established immortalised cell lines — robust, undemanding
  • Immunoassay matrix and diagnostic background — you need a human matrix, not growth factors
  • Blocking and stabilisation in assay buffers
  • Protein standards and reference material

Paying an off-the-clot premium for these applications spends budget without a return.

How to find out what you are currently using

Many datasheets do not state it. Ask directly.

On the certificate of analysis or the datasheet, look for these terms:

WordingMeans
Off-the-clot · from whole blood · natural clotting · no anticoagulantOff-the-clot
Recalcified · plasma-derived · from plasma · defibrinated plasmaNot off-the-clot
Source: plasmapheresis · apheresis plasmaAlmost certainly recalcified
No statement at allAsk. Suppliers who collect off-the-clot say so, because it is a selling point.

If you are qualifying a new supplier, put the question in the specification rather than the enquiry email. A supplier who cannot answer it in writing is telling you something.

One common confusion worth clearing up

Plasma-derived serum is not plasma. Plasma still contains fibrinogen and the full complement of coagulation factors. Plasma-derived serum has been clotted and the fibrin removed — it is serum, just made by a different route.

If your application genuinely needs plasma, that is a separate product with separate specifications: human plasma and apheresis plasma.

Frequently asked questions

What does off-the-clot mean?

The serum was obtained from whole blood that clotted naturally, without any anticoagulant at any stage and without artificial recalcification. The coagulation cascade runs its physiological course.

Is off-the-clot serum always better?

No. It is better where the growth factor profile or free calcium matters — MSC expansion, primary cells, calcium-dependent assays. For established cell lines and diagnostic matrix applications it offers no measurable advantage over recalcified serum.

Does residual citrate really affect cell culture?

It lowers the free calcium concentration available in the medium, because citrate binds calcium. Whether that reaches your cells depends on the amount and on how calcium-sensitive your system is. For integrin-mediated adhesion and calcium signalling it is a real variable; for routine culture it usually is not.

Why is my serum forming strings or gel after thawing?

Residual fibrinogen is a likely explanation, and incomplete recalcification is a common cause. Off-the-clot serum has essentially no fibrinogen left, because clotting ran to completion before the serum was separated.

Can I combine off-the-clot with Type AB and male donors?

Yes, those attributes are independent. Availability drops with each additional constraint, so confirm current stock before you write the combination into a specification.

How do I check what my current supplier delivers?

Look for "off-the-clot", "from whole blood" or "no anticoagulant" on the datasheet. If the wording is "recalcified", "plasma-derived" or "from plasma", it is not off-the-clot. If there is no statement, ask in writing.

Does off-the-clot matter for immunoassay applications?

Usually not. There you need a representative human matrix rather than a growth factor profile, and pooled standard serum is generally the right choice. See human serum for immunoassays.

Can I get a sample before committing?

Yes. With serum, testing your own cells against the specific lot is the only reliable qualification — specifications do not capture everything that matters.

Test it against your own cells

Specifications only take you so far with serum. Tell us the cell type and the application — we will send a free sample of the variant that fits, with the full documentation.

Request a free sample

Need a Lot Reservation or Test Sample?

Reserve your validated FBS or human serum lot — no prepayment.
Free test samples on request.

Name
+49 851 xxxx
How did you find us?